Compositions and methods for the treatment of mucositis

Details for Australian Patent Application No. 2007275658 (hide)

Owner Resolvyx Pharmaceuticals, Inc.

Inventors Gjorstrup, Per; Schwartz, C. Eric

Agent Shelston IP

Pub. Number AU-B-2007275658

PCT Pub. Number WO2008/011085

Priority 60/831,866 19.07.06 US

Filing date 19 July 2007

Wipo publication date 24 January 2008

Acceptance publication date 1 September 2011

International Classifications

A61K 31/202 (2006.01)

A61K 31/232 (2006.01)

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

12 February 2009 PCT application entered the National Phase

  PCT publication WO2008/011085 Priority application(s): WO2008/011085

1 September 2011 Application Accepted

  Published as AU-B-2007275658

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007275660-Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease

2007275654-WSX-1/p28 as a target for antiinflammatory responses